Takeda Pharmaceutical Price Target Raised to $20.74 as Analysts Maintain Buy Rating
Wall Street analysts covering Takeda Pharmaceutical Company Limited (TSE:4502) raised their average 12-month price target on the stock to $20.74, up from $20.58. The average estimate comes from 14 analysts, with individual price targets ranging between $16.96 and $23.36 per share. Following the update, shares rose 3.89% to 6,118 JPY.
The revised price objective indicates a potential upside of approximately 9% based on the October 14 closing price. Analyst sentiment remains supportive of the Japanese drugmaker, with a consensus rating of Buy across 17 covering analysts. Among those tracked, 10 maintain a Buy rating, 7 issue a Hold, and none recommend Selling the stock.
Investors will be watching whether upcoming financial results and drug pipeline developments can help the stock move toward analyst price targets, alongside any further shifts in consensus recommendations.
Key points
- Analysts increased Takeda Pharmaceutical's average 12-month price target from $20.58 to $20.74.
- The price target range spans from $16.96 on the low end to $23.36 on the high end across 14 estimates.
- The updated price target implies roughly 9% potential upside from the October 14 closing price.
- Consensus rating stays at Buy among 17 analysts, with 10 Buys, 7 Holds, and 0 Sells.
- Shares of Takeda Pharmaceutical gained 3.89% today to trade at 6,118 JPY.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
What is the updated price target for Takeda Pharmaceutical stock?
Analysts raised the average 12-month price target for Takeda Pharmaceutical Company Limited to $20.74, up from $20.58. Individual forecasts range from $16.96 to $23.36 per share.
What is the analyst consensus rating for Takeda Pharmaceutical?
The overall consensus rating for Takeda Pharmaceutical is Buy, based on 17 analysts. The breakdown includes 10 Buy ratings, 7 Hold ratings, and zero Sell recommendations.
How much upside does the updated target imply for Takeda stock?
Based on the closing price from October 14, the average price target of $20.74 represents approximately 9% potential upside.